Characteristic | All Presentations (n = 17,724) | High Acuity (CTAS 1/2) (n = 4,468) | Moderate Acuity (CTAS 3) (n = 9,379) | Low Acuity (CTAS 4/5) (n = 3,877) |
---|---|---|---|---|
Sex, n (%) | ||||
Female | 10,400 (58.7) | 2,629 (58.8) | 5,628 (60.0) | 2,143 (55.3) |
Male | 7,324 (41.3) | 1,839 (41.2) | 3,751 (40.0) | 1,734 (44.7) |
Age (years), median [IQR] | 32.7 [24.8, 42.5] | 34.5 [25.7, 44.4] | 32.4 [24.7, 42.3] | 31.7 [24.5, 40.9] |
Zone of residence, n (%) | ||||
North | 1,592 (9.0) | 169 (3.8) | 846 (9.0) | 577 (14.9) |
Edmonton | 5,305 (29.9) | 1,883 (42.1) | 2,459 (26.2) | 963 (24.8) |
Central | 994 (5.6) | 225 (5.0) | 542 (5.8) | 227 (5.9) |
Calgary | 7,053 (39.8) | 1,759 (39.4) | 4,337 (46.2) | 957 (24.7) |
South | 2,747 (15.5) | 423 (9.5) | 1,178 (12.6) | 1,146 (29.6) |
Missing | 33 (0.2) | 9 (0.2) | 17 (0.2) | 7 (0.2) |
Neighborhood income quintile, n (%) | ||||
1 Lowest | 3,788 (21.4) | 1,005 (22.5) | 2,009 (21.4) | 774 (20.0) |
2 | 3,430 (19.4) | 853 (19.1) | 1,804 (19.2) | 773 (19.9) |
3 | 3,015 (17.0) | 714 (16.0) | 1,603 (17.1) | 698 (18.0) |
4 | 3,068 (17.3) | 662 (14.8) | 1,714 (18.3) | 692 (17.8) |
5 Highest | 2,261 (12.8) | 509 (11.4) | 1,203 (12.8) | 549 (14.2) |
Missing | 2,162 (12.2) | 725 (16.2) | 1,046 (11.2) | 391 (10.1) |
Community size, n (%) | ||||
≥ 100,000 | 10,754 (60.6) | 3,032 (67.9) | 6,016 (64.1) | 1,706 (44.0) |
10,000 to 99,999 | 4,142 (23.4) | 555 (12.4) | 1,979 (21.1) | 1,608 (41.5) |
< 10,000 | 753 (4.2) | 178 (4.0) | 387 (4.1) | 188 (4.8) |
Missing | 2,075 (11.7) | 703 (15.7) | 997 (10.6) | 375 (9.7) |
ED category, n (%) | ||||
Regional | 5,240 (29.6) | 733 (16.4) | 2,493 (26.6) | 2,014 (51.9) |
Urban | 9,188 (51.8) | 2,662 (59.6) | 5,184 (55.3) | 1,342 (34.6) |
Academic/teaching | 3,296 (18.6) | 1,073 (24.0) | 1,702 (18.1) | 521 (13.4) |
Fiscal year, n (%) | ||||
2014/2015 | 4,042 (22.8) | 894 (20.0) | 2,244 (23.9) | 904 (23.3) |
2015/2016 | 3,775 (21.3) | 927 (20.7) | 2,046 (21.8) | 802 (20.7) |
2016/2017 | 3,341 (18.9) | 885 (19.8) | 1,752 (18.7) | 704 (18.2) |
2017/2018 | 3,278 (18.5) | 886 (19.8) | 1,644 (17.5) | 748 (19.3) |
2018/2019 | 3,288 (18.6) | 876 (19.6) | 1,693 (18.1) | 719 (18.5) |
Month of year, n (%) | ||||
January | 1,432 (8.1) | 343 (7.7) | 737 (7.9) | 352 (9.1) |
February | 1,254 (7.1) | 300 (6.7) | 669 (7.1) | 285 (7.4) |
March | 1,338 (7.5) | 344 (7.7) | 690 (7.4) | 304 (7.8) |
April | 1,346 (7.6) | 318 (7.1) | 719 (7.7) | 309 (8.0) |
May | 1,456 (8.2) | 342 (7.7) | 774 (8.3) | 340 (8.8) |
June | 1,358 (7.7) | 335 (7.5) | 723 (7.7) | 300 (7.7) |
July | 1,478 (8.3) | 390 (8.7) | 790 (8.4) | 298 (7.7) |
August | 1,577 (8.9) | 401 (9.0) | 852 (9.1) | 324 (8.4) |
September | 1,990 (11.2) | 524 (11.7) | 1,090 (11.6) | 376 (9.7) |
October | 1,678 (9.5) | 452 (10.1) | 866 (9.2) | 360 (9.3) |
November | 1,328 (7.5) | 342 (7.7) | 720 (7.7) | 266 (6.9) |
December | 1,489 (8.4) | 377 (8.4) | 749 (8.0) | 363 (9.4) |
Day of week, n (%) | ||||
Weekday (Mon-Fri) | 12,490 (70.5) | 3,146 (70.4) | 6,643 (70.8) | 2,701 (69.7) |
Weekend (Sat, Sun) | 5,234 (29.5) | 1,322 (29.6) | 2,736 (29.2) | 1,176 (30.3) |
Time of day, n (%) | ||||
Day (08:01–16:00) | 6,493 (36.6) | 1,496 (33.5) | 3,372 (36.0) | 1,625 (41.9) |
Evening (16:01–24:00) | 6,866 (38.7) | 1,850 (41.4) | 3,612 (38.5) | 1,404 (36.2) |
Night (00:01–08:00) | 4,351 (24.5) | 1,119 (25.0) | 2,389 (25.5) | 843 (21.7) |
Charlson Comorbidity Score, median [IQR] | 1.0 [1.0, 1.0] | 1.0 [1.0, 1.0] | 1.0 [1.0, 1.0] | 1.0 [0.0, 1.0] |
Charlson Comorbidities, n (%) | ||||
Diabetes mellitus | 748 (4.2) | 286 (6.4) | 364 (3.9) | 98 (2.5) |
Cancer | 343 (1.9) | 88 (2.0) | 185 (2.0) | 70 (1.8) |
Mild/moderate/severe liver disease | 174 (1.0) | 50 (1.1) | 89 (0.9) | 35 (0.9) |
Rheumatic | 150 (0.8) | 44 (1.0) | 79 (0.8) | 27 (0.7) |
Congestive heart failure | 139 (0.8) | 72 (1.6) | 56 (0.6) | 11 (0.3) |
Stroke | 126 (0.7) | 41 (0.9) | 60 (0.6) | 25 (0.6) |
Renal | 103 (0.6) | 44 (1.0) | 51 (0.5) | 8 (0.2) |
Peptic ulcer disease | 69 (0.4) | 21 (0.5) | 30 (0.3) | 18 (0.5) |
Paralysis | 41 (0.2) | 17 (0.4) | 21 (0.2) | 3 (0.1) |
Acute myocardial infarction | 40 (0.2) | 9 (0.2) | 25 (0.3) | 6 (0.2) |
Peripheral vascular disorders | 37 (0.2) | 19 (0.4) | 16 (0.2) | 2 (0.1) |
Dementia | 36 (0.2) | 12 (0.3) | 20 (0.2) | 4 (0.1) |
HIV/AIDS | 30 (0.2) | 13 (0.3) | 12 (0.1) | 5 (0.1) |